XINTRAQ Trademark

Trademark Overview

On Thursday, March 2, 2023, a trademark application was filed for XINTRAQ with the United States Patent and Trademark Office. The USPTO has given the XINTRAQ trademark a serial number of 97820654. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2024. This trademark is owned by MAIA PHARMACEUTICALS, INC.. The XINTRAQ trademark is filed in the Pharmaceutical Products category with the following description:

Gastro-intestinal treatment preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of gallbladder and pancreas disorders; Pharmaceutical preparations for the treatment and prevention of gallbladder, intestinal tract, and pancreas disorders; Pharmaceutical preparations for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for assisting in the diagnosis of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body; Pharmaceutical preparations, namely, elixirs for the treatment of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body
xintraq

General Information

Serial Number97820654
Word MarkXINTRAQ
Filing DateThursday, March 2, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesGastro-intestinal treatment preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of gallbladder and pancreas disorders; Pharmaceutical preparations for the treatment and prevention of gallbladder, intestinal tract, and pancreas disorders; Pharmaceutical preparations for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for assisting in the diagnosis of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body; Pharmaceutical preparations, namely, elixirs for the treatment of gallbladder and pancreas disorders, stimulating gallbladder contraction, stimulating pancreas secretion, and accelerating the transit of barium through the human body

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMAIA PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameMAIA PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Thursday, November 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 6, 2023NEW APPLICATION ENTERED
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 7, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 7, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

xintraq preparations pharmaceutical pancreas gallbladder disorders treatment stimulating intestinal barium through